Rebecca Love
Themes it raises
FDA questions it names
Q2 · The spectrum of device activityQ3 · When an output becomes directiveQ6 · Care escalation functionsQ17 · Devices with many functions
The comment as filed
Re: FDA-2026-N-7874 — Considerations for the Regulation of Generative AI-Enabled Medical Devices: Discussion Paper and Request for Feedback
I am an RN, MSN with 21 years of experience working at the bedside on a medical-surgical unit. I am submitting this comment in response to the request for feedback above.
My comments come from direct experience with these AI tools: ambient AI scribes; early-warning alerts such as sepsis alerts; patient chatbots or AI-drafted portal replies; AI triage tools; AI-written patient education.
Regarding Question 2 (When does information become an instruction): In my work, I have seen education is the best for AI to better help patients inform their decisions.
Regarding Question 3 (Are AI tools that talk to patients riskier): I think this is helpful at times, but knowing when there is providing education - vs diagnosing is where things need to go to a human.
Regarding Question 6 (Missed escalations and false alarms): In my work, I have seen not seen it at the bedside but via ambulatory call centers - many AI bots are doing triage which is outside the scope of practice without FDA clearance and oversight.
Regarding Question 17 (AI that listens, sees, or records): In my work, I have seen AI scribes about 70% accurate - mostly because they fail on transcription accuracy.
Thank you for considering these comments.
Sincerely,
Rebecca Love, RN, MSN